Silicate fiber-based 3D cell culture system for anticancer drug screening

Area of Science:

• Biomedical Engineering
• Cancer Research
• Drug Discovery

Background:

• Three-dimensional (3D) in vitro cultures offer a more physiologically relevant microenvironment compared to traditional 2D cultures.
• 3D modeling techniques are increasingly explored for their utility in anticancer drug screening.
• Understanding the tumor microenvironment is crucial for developing effective cancer therapies.

Purpose of the Study:

• To evaluate a silicate fiber scaffold-based 3D cell culture system for its ability to model human tumors.
• To assess the efficacy of anticancer drugs, specifically mytomicin C and doxorubicin, in this 3D model.
• To compare drug resistance and molecular profiles of cancer cells in 3D versus 2D cultures.

Main Methods:

• Utilized a silicate fiber scaffold for establishing 3D cell cultures with 13 human tumor cell lines.
• Modeled the efficacy of mytomicin C and doxorubicin in the 3D culture system.
• Quantified drug resistance, lactate production, and expression of nuclear factor-kappa B (NF-κB)-regulated genes (BCL2, COX2, VEGF).

Main Results:

• A unique 3D cellular structure was observed across 13 human tumor cell lines cultured on the scaffold.
• Cancer cells in 3D cultures demonstrated significantly higher resistance to anticancer drugs compared to cells in 2D cultures.
• Elevated levels of lactate production and expression of NF-κB-regulated genes (BCL2, COX2, VEGF) were noted in 3D cultures.

Conclusions:

• The silicate fiber scaffold effectively mimics key features of the cancer microenvironment in vitro.
• This 3D culture system provides a suitable platform for evaluating the efficacy of anticancer drugs.
• The findings support the use of 3D models for more accurate preclinical drug testing in oncology.